HSR21-047: Tumor Lysis Syndrome Risk Analysis in a US Community Oncology Setting: A Retrospective Observational Study in Integra Connect Network

View More View Less
  • 1 Sanofi-Genzyme, Cambridge, MA
  • | 2 Integra Connect, West Palm Beach, FL
Restricted access

Corresponding Author: Kaustav Chatterjee, MD